SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Novelix Pharmaceuticals jumps on entering into agreement with GMBU e.V., Halle

04 Jun 2026 Evaluate

Novelix Pharmaceuticals is currently trading at Rs. 59.00, up by 4.64 points or 8.54% from its previous closing of Rs. 54.36 on the BSE.

The scrip opened at Rs. 57.00 and has touched a high and low of Rs. 60.00 and Rs. 56.30 respectively. So far 18527 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 70.16 on 19-Nov-2025 and a 52 week low of Rs. 29.33 on 9-Jun-2025.

Last one week high and low of the scrip stood at Rs. 60.00 and Rs. 50.60 respectively. The current market cap of the company is Rs. 140.98 crore.

The promoters holding in the company stood at 49.43%, while Non-Institutions held 50.57% stake in the company. 

Novelix Pharmaceuticals has entered into an agreement with GMBU e.V., Halle (Saale), Germany for the production scale up of Astaxanthin at commercial level at the company’s research facilities in Hyderabad, India after the success of pilot scale production. 

Novelix Pharmaceuticals is an innovation-driven biopharmaceutical company based in Hyderabad, India, focused on novel therapeutics, advanced biologics, and nutraceutical research.

Novelix Pharma Share Price

59.62 5.26 (9.68%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 247.05
Amrapali Industries 18.64
Adani Enterprises 2972.80
Rashi Peripheral 539.45
PDS 319.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×